Skip to search formSkip to main contentSkip to account menu

Thrombopoietin Receptor Agonists [MoA]

Known as: Thrombopoietin Receptor Agonists 
National Institutes of Health

Related topics

Related topics

3 relations
eltrombopageltrombopag 25 MG Oral Tabletromiplostim

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Фармакоэкономический анализ применения агонистов рецепторов тромбопоэтина для терапии хронической идиопатической тромбоцитопенической пурпуры у взрослых
Actuallity. Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease caused by the production of antibodies to the… 
2017
2017
Therapeutic Use of Thrombopoietin Receptor Agonists
Discoveries throughout the twentieth century have forged our understanding of platelet production and including the variables… 
2016
2016
CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been… 
2015
2015
CP-080 Thrombopoietin receptor agonist treatment in idiopathic thrombocytopenic purpura
Background Idiopathic thrombocytopenic purpura (ITP) is a disease characterised by decreased platelet count. Romiplostim and… 
Review
2013
Review
2013
Bone Marrow Fibrosis In Immune Thrombocytopenia (ITP) Patients Treated With Thrombopoietin Receptor Agonists (TRA) – a Single Center Long-Term Follow-Up
![Graphic][1] Introduction TRAs increase platelet counts by stimulating the TPO-receptor. A known effect of TRA treatment is… 
2013
2013
Análisis del coste del tratamiento farmacológico de la trombocitopenia inmune primaria mediante agonistas del receptor de la trombopoyetina en España
ResumenObjetivoAnalizar el coste del tratamiento farmacológico de la trombocitopenia inmune primaria (PTI) con agonistas del… 
2011
2011
Фармакоэкономический анализ применения мовалиса (мелоксикам) у больных с неспецифической болью в спине
The paper analyzes the use of movalis (meloxicam) in 150 patients with nonspecific back pain in the outpatient setting. Movalis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)